Botulinum toxin treatment of apraxia of eyelid opening in progressive supranuclear palsy: Report of two cases

Archives of Physical Medicine and Rehabilitation

Volumn 78, Issue 5, 1997, Pages 525-529

  Piccione, Francesco ^a   Mancini, Elena ^a   Tonin, Paolo ^a   Bizzarini, Massimo ^b  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b Medical Oncology Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; APRAXIA; ARTICLE; BLINDNESS; CASE REPORT; DRUG EFFICACY; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY; TREATMENT OUTCOME;

EID: 0030990707     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(97)90169-6     Document Type: Article

References (21)

1. Krack P, Marion MH. "Apraxia of lid opening", a focal eyelid dystonia: clinical study of 32 patients. Mov Disord 1994;6:610-5.
2. Friedman DI, Jankovic J, McCrary III JA. Neuro-ophthalmic findings in progressive supranuclear palsy. J Clin Neuroophthalmol 1992;12:104-9.
3. Lepore FE, Duvoisin RC. "Apraxia" of eyelid opening: an involuntary levator inhibition. Neurology 1985;35:423-7.
4. Elston JS. A new variant of blepharospasm. J Neurol Neurosurg Psychiatry 1992;55:369-71.
5. Aramideh M, Ongerboer de Visser BW, Koelman JHTM, Speelman JD. Motor persistence of orbicularis oculi muscle in eyelid-opening disorders. Neurology 1995;45:897-902.
6. Canter CJ, De La Torre R, Mier M. A method for evaluating disability in patients with Parkinson's disease. J Nerv Mental Disord 1961; 133:143-7.
7. Aramideh M, Ongerboer de Visser BW, Devriese PP, Bour LJ, Speelman JD. Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm. Brain 1994; 117:27-38.
8. Kimura J. Disorder of interneurons in parkinsonism. The orbicularis oculi reflex to paired stimuli. Brain 1973;96:87-96.
9. Eleopra R, Tugnoli V, Caniatti L, De Grandis D. Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion. Neurology 1996;46:1158-60.
10. Rivest J, Quinn N, Mardsen CD. Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurology 1990;40:1571-8.
11. Rafal RD, Friedman JH. Limb dystonia in progressive supranuclear palsy. Neurology 1987;37:1546-9.
12. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995;58:167-73.
13. Daniel SE, de Bruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995;118:759-70.
14. Colosimo C, Albanese A, Hughes AJ, de Bruin VMS, Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995; 52:294-8.
15. Berardelli A, Rothwell JC, Day BL, Marsden CD. Pathophysiology of blepharospasm and oromandibular dystonia. Brain 1985;108: 593-608.
16. Eekhof JLA, Aramideh M, Bour LJ, Hilgevoord AAJ, Speelman HD, Ongerboer de Visser BW. Blink reflex recovery curves in blepharospasm, torticollis spasmodica, and hemifacial spasm. Muscle Nerve 1995;19:10-5.
17. Valls-Sole J, Tolosa ES, Ribera G. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm. J Neurol Neurosurg Psychiatry 1991;54:310-3.
18. Aramideh M, Ongerboer de Visser BW, Brans JWM, Koelman JHTM, Speelman JD. Pretarsal application of botulinum toxin for treatment of blepharospasm. J Neurol Neurosurg Psychiatry 1995; 59:309-11.
19. Dam M, Tonin P, Casson S, Bracco F, Piron L, Pizzolato G, et al. Effects of conventional and sensory-enhanced physiotherapy on disability of Parkinson's disease patients. Adv Neurol 1996;69:551-5.
20. Sosner J, Wall GC, Sznajder J. Progressive supranuclear palsy: clinical presentation and rehabilitation of two patients. Arch Phys Med Rehabil 1993;74:537-9.
21. Polo KB, Jabbari B. Botulinum toxin-A improves the rigidity of progressive supranuclear palsy. Ann Neurol 1994;35:237-9.